Gilead Sciences (NASDAQ:GILD)

self checkout

4 Jefferies Stealth Stock Picks for a Very Volatile Market

We are having trading days that some on Wall Street can become very scared of. Big moves up and down, with little or no real reason behind the selling other ...
Read Full Story »
biotech word cloud

Short Sellers Run for Cover From Major Biotechs

Companies within the biotech industry are considered a riskier group of stocks, with big potential upside and big potential downside. In fact, a cure or incredible new breakthrough in cancer ...
Read Full Story »
analysis

Top Analyst Upgrades and Downgrades: Colgate-Palmolive, Gilead, Navistar, Occidental, Pandora, Wal-Mart and More

Stocks were marginally lower, but that is tracking Europe lower after U.S. markets were slammed lower on Friday. It is important to realize that it had been almost two months ...
Read Full Story »
thumbs up and down

Major Blue Chip Analyst Upgrades and Downgrades in Apple, Intel, Caterpillar, Gilead, JPMorgan and Nike

The week of September 9 ended on a sour note after more Federal Reserve jawboning about the need for rate hikes ahead. Regardless of any market weakness, the reality is that ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: Biogen, Broadcom, Devon Energy, Gilead, Mondelez, Urban Outfitters and More

Stocks were indicated marginally higher after the long weekend. With the Dow and S&P 500 being so close to all-time highs, investors have proven over and over that they will ...
Read Full Story »
Stock Price

Bristol-Myers, Verifone Dive into Friday’s 52-Week Low Club

September 2, 2016: Here are four stocks trading with relatively heavy volume among 21 equities making new 52-week lows in Friday's session. NYSE advancers led decliners by nearly 4 to ...
Read Full Story »
Stock Price

Oil Drillers Noble and Ensco Join Gilead in Thursday’s 52-Week Low Club

September 1, 2016: Here are four stocks trading with relatively heavy volume among 39 equities making new 52-week lows in Thursday's session. NYSE decliners led advancers by about 5 to ...
Read Full Story »
Stock Price

Gilead Sciences, G-III Top Wednesday’s 52-Week Low Club

August 31, 2016: Here are four stocks trading with relatively heavy volume among 27 equities making new 52-week lows in Wednesday's session. NYSE decliners led advancers by 3 to 2 ...
Read Full Story »
buy sell

Top Analyst Upgrades and Downgrades: Abercrombie, Alibaba, Baidu, First Data, Marvell Technology, Under Armour and More

Stocks are very close to all-time highs, but the markets were looking for direction after the ADP payrolls report did not create any massive buzz one way or another ahead ...
Read Full Story »
Stock Price

Gilead, Ceasars in Monday’s 52-Week Low Club

August 29, 2016: Here are four stocks trading with relatively heavy volume among 21 equities making new 52-week lows in Monday's session. NYSE advancers led decliners by about 7 to ...
Read Full Story »
biotech word cloud

Short Sellers Increase Bets in Major Biotechs

The short interest data are out for the August 15 settlement date. Companies within the biotech industry are considered a riskier group of stocks, with big potential upside and big ...
Read Full Story »
money

How Much Medivation Can Really Fetch in a Buyout

Medivation Inc. (NASDAQ: MDVN) has been among the top future biotech mergers for quite some time. The problem is that we still have no idea which company will buy Medivation, ...
Read Full Story »
automatic inspection machine

Why Jefferies Sees 3 Big Biotechs Having Key Upside Catalysts Coming

After a year of being beaten down by legions of sellers, the biotech segment of the health care sector is finally starting to make a move back for investors, and the ...
Read Full Story »
automatic inspection machine

Short Sellers Run for Cover From Major Biotechs

The short interest data are out for the July 29 settlement date. Companies within the biotech industry are considered a riskier group of stocks, with big potential upside and big ...
Read Full Story »
buy now

RBC Says Buy Big Biotechs Now for Possible Big 2016 Gains

We have talked about it for months here at 24/7 Wall St., and now many on Wall Street are talking about it as well. The selling in biotech, much of ...
Read Full Story »